PRF1 and neoplasm: An earlier onset of palpable tumors (Figure 4A), reduced overall survival rate (Figure 4B), and increased tumor multiplicity (Figure 4C) were observed in neuT female mice lacking perforin (neuT-pfpKO), as compared to their fully immune competent counterpart.